These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17884183)

  • 1. CCL5 and CCR5 genotypes modify clinical, radiological and pathological features of multiple sclerosis.
    van Veen T; Nielsen J; Berkhof J; Barkhof F; Kamphorst W; Bö L; Ravid R; Verweij CL; Huitinga I; Polman CH; Uitdehaag BM
    J Neuroimmunol; 2007 Oct; 190(1-2):157-64. PubMed ID: 17884183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.
    Kantarci OH; Morales Y; Ziemer PA; Hebrink DD; Mahad DJ; Atkinson EJ; Achenbach SJ; De Andrade M; Mack M; Ransohoff RM; Lassmann H; Bruck W; Weinshenker BG; Lucchinetti CF
    J Neuroimmunol; 2005 Dec; 169(1-2):137-43. PubMed ID: 16182378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CCL5 and CCR5 gene polymorphisms with periodontitis in Taiwanese.
    Shih YS; Fu E; Fu MM; Lin FG; Chiu HC; Shen EC; Chiang CY
    J Periodontol; 2014 Nov; 85(11):1596-602. PubMed ID: 25119558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
    Li H; Liu TJ; Hong ZH
    Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine receptor CCR5 in interferon-treated multiple sclerosis.
    Sellebjerg F; Kristiansen TB; Wittenhagen P; Garred P; Eugen-Olsen J; Frederiksen JL; Sørensen TL
    Acta Neurol Scand; 2007 Jun; 115(6):413-8. PubMed ID: 17511851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of CC chemokine ligand 5 and CC chemokine receptor 5 genes polymorphisms on the risk and clinicopathological development of oral cancer.
    Weng CJ; Chien MH; Lin CW; Chung TT; Zavras AI; Tsai CM; Chen MK; Yang SF
    Oral Oncol; 2010 Oct; 46(10):767-72. PubMed ID: 20729133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
    Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
    Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CCR5 delta32 deletion with early death in multiple sclerosis.
    Gade-Andavolu R; Comings DE; MacMurray J; Rostamkhani M; Cheng LS; Tourtellotte WW; Cone LA
    Genet Med; 2004; 6(3):126-31. PubMed ID: 15354329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
    Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
    J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of the chemokine receptor CCR5 in tick-borne encephalitis.
    Grygorczuk S; Osada J; Parczewski M; Moniuszko A; Świerzbińska R; Kondrusik M; Czupryna P; Dunaj J; Dąbrowska M; Pancewicz S
    J Neuroinflammation; 2016 Feb; 13():45. PubMed ID: 26906062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
    Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
    Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
    Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
    J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions.
    Mahad DJ; Trebst C; Kivisäkk P; Staugaitis SM; Tucky B; Wei T; Lucchinetti CF; Lassmann H; Ransohoff RM
    J Neuropathol Exp Neurol; 2004 Mar; 63(3):262-73. PubMed ID: 15055450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of methylprednisolone and mitoxantrone on CCL5-induced migration of lymphocytes in multiple sclerosis.
    Jalosinski M; Karolczak K; Mazurek A; Glabinski A
    Acta Neurol Scand; 2008 Aug; 118(2):120-5. PubMed ID: 18336625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
    Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I
    J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of CCL5 -403 G>A and CCR5 Δ32 gene polymorphisms in patients with breast cancer.
    Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S; Bahari G; Mashhadi MA; Taheri M
    Cancer Biomark; 2014; 14(5):343-51. PubMed ID: 25171476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.
    Trebst C; Sørensen TL; Kivisäkk P; Cathcart MK; Hesselgesser J; Horuk R; Sellebjerg F; Lassmann H; Ransohoff RM
    Am J Pathol; 2001 Nov; 159(5):1701-10. PubMed ID: 11696431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
    Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
    Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease.
    Huerta C; Alvarez V; Mata IF; Coto E; Ribacoba R; Martínez C; Blázquez M; Guisasola LM; Salvador C; Lahoz CH; Peña J
    Neurosci Lett; 2004 Nov; 370(2-3):151-4. PubMed ID: 15488313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.